TABLE 6.

Estimated accuracy measures for a MI risk model with clinical predictors and biomarkers WPA1 and apoE and the incremental values (incV) of WPA1 and apoE over a model with only clinical predictors.

measure	FPR	est (95% CI)	incv (95% CI)
TPR	0.050	0.265 (0.146, 0.385)	−0.022 (−0.106, 0.061)
PPV	0.050	0.021 (0.009, 0.033)	−0.001 (−0.009, 0.007)
NPV	0.050	0.997 (0.996, 0.998)	0.000 (−0.000, 0.000)
TPR	0.100	0.360 (0.234, 0.487)	0.001 (−0.081, 0.083)
PPV	0.100	0.014 (0.008, 0.021)	−0.001 (−0.005, 0.004)
NPV	0.100	0.997 (0.996, 0.998)	0.000 (−0.000, 0.000)
TPR	0.200	0.503 (0.378, 0.627)	0.025 (−0.065, 0.115)
PPV	0.200	0.010 (0.007, 0.014)	0.000 (−0.002, 0.003)
NPV	0.200	0.998 (0.997, 0.998)	0.000 (−0.000, 0.001)
AUC		0.688 (0.610, 0.765)	−0.005 (−0.057, 0.047)